Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome
Sponsor: Nilratan Sircar Medical College
Listed as NCT02382575, this PHASE4 trial focuses on Nephrotic Syndrome and remains ongoing. Sponsored by Nilratan Sircar Medical College, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2024 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
May 2022 — May 2024 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Mar 2022 — May 2022 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2019 — Mar 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nilratan Sircar Medical College
For direct contact, visit the study record on ClinicalTrials.gov .